CYTH · Categories · Form 4

CYTH - SEC Form 4 insider transactions

Cyclo Therapeutics Inc. (CYTH) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for CYTH

• 471d
  Director Conkling William was granted 27,654 shares, increasing direct ownership by 55% to 77,884 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 471d
  Director Wong Vivien was granted 25,140 shares, increasing direct ownership by 63% to 64,853 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 471d
  Director Cross Shawn was granted 28,597 shares, increasing direct ownership by 27% to 136,346 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 471d
  Director Toig Randall M. was granted 33,311 shares, increasing direct ownership by 23% to 179,137 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 471d
  Director Strattan Ce Rick was granted 30,169 shares, increasing direct ownership by 8% to 399,272 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 471d
  Director Ostronic Francis Patrick was granted 70,329 shares, increasing direct ownership by 20% to 419,100 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 471d
  Director Sieger Markus was granted 58,138 shares, increasing direct ownership by 15% to 440,260 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 474d
  Director Shanahan William S was granted 25,140 shares, increasing direct ownership by 17% to 173,966 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 576d
  Director Conkling William was granted 16,660 shares, increasing direct ownership by 50% to 50,230 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 576d
  Director Cross Shawn was granted 17,228 shares, increasing direct ownership by 19% to 107,749 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 576d
  Director Shanahan William S was granted 15,145 shares, increasing direct ownership by 11% to 148,826 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 576d
  Director Sieger Markus was granted 35,022 shares, increasing direct ownership by 10% to 382,122 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 576d
  Director Strattan Ce Rick was granted 63,608 shares, increasing direct ownership by 21% to 369,103 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 576d
  Director Toig Randall M. was granted 20,067 shares, increasing direct ownership by 16% to 145,826 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 576d
  Director Wong Vivien was granted 15,145 shares, increasing direct ownership by 62% to 39,713 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 666d
  Director Shanahan William S was granted 7,937 shares, increasing direct ownership by 6% to 133,681 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 666d
  Director Conkling William was granted 8,731 shares, increasing direct ownership by 35% to 33,570 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 666d
  Director Cross Shawn was granted 9,028 shares, increasing direct ownership by 11% to 90,521 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 666d
  Director Wong Vivien was granted 7,937 shares, increasing direct ownership by 48% to 24,568 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 666d
  Director Toig Randall M. was granted 10,516 shares, increasing direct ownership by 9% to 125,759 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 666d
  Director Strattan Ce Rick was granted 9,524 shares, increasing direct ownership by 3% to 305,495 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 666d
  Director Sieger Markus was granted 18,354 shares, increasing direct ownership by 6% to 347,100 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 742d
  Shanahan William S was granted 7,813 shares, increasing direct ownership by 7% to 125,744 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 742d
  SEC Form 4 filed by Fine Joshua M

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 742d
  SEC Form 4 filed by Tate Jeffrey

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 742d
  SEC Form 4 filed by Lisjak Michael Eric

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 742d
  Sieger Markus was granted 18,067 shares, increasing direct ownership by 6% to 328,746 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 742d
  Ostronic Francis Patrick was granted 10,743 shares, increasing direct ownership by 3% to 348,771 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 742d
  Strattan Ce Rick was granted 9,375 shares, increasing direct ownership by 3% to 295,971 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 742d
  Toig Randall M. was granted 10,352 shares, increasing direct ownership by 10% to 115,243 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 742d
  Cross Shawn was granted 8,887 shares, increasing direct ownership by 12% to 81,493 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 742d
  SEC Form 4 filed by Fine N Scott

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 742d
  Wong Vivien was granted 7,813 shares, increasing direct ownership by 89% to 16,631 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 742d
  Conkling William was granted 8,594 shares, increasing direct ownership by 53% to 24,839 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 853d
  Sieger Markus was granted 14,004 shares, increasing direct ownership by 5% to 310,679 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 853d
  Ostronic Francis Patrick was granted 8,703 shares, increasing direct ownership by 3% to 338,028 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 853d
  Toig Randall M. was granted 7,516 shares, increasing direct ownership by 8% to 104,891 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 853d
  Strattan Ce Rick was granted 6,963 shares, increasing direct ownership by 2% to 286,596 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 853d
  Wong Vivien was granted 6,330 shares, increasing direct ownership by 254% to 8,818 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 853d
  Conkling William was granted 6,330 shares, increasing direct ownership by 64% to 16,245 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 853d
  Shanahan William S was granted 8,466 shares, increasing direct ownership by 8% to 117,931 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 902d
  Cross Shawn was granted 72,606 shares (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 930d
  Conkling William was granted 7,466 shares, increasing direct ownership by 305% to 9,915 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 930d
  Ostronic Francis Patrick was granted 10,262 shares, increasing direct ownership by 3% to 329,325 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 930d
  Wong Vivien was granted 2,488 shares (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 930d
  Shanahan William S was granted 9,982 shares, increasing direct ownership by 10% to 109,465 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 930d
  Toig Randall M. was granted 8,862 shares, increasing direct ownership by 10% to 97,375 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 930d
  Sieger Markus was granted 16,512 shares, increasing direct ownership by 6% to 296,675 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 930d
  Strattan Ce Rick was granted 8,209 shares, increasing direct ownership by 3% to 279,633 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 960d
  Strattan Ce Rick was granted 42,599 shares, increasing direct ownership by 19% to 271,424 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 968d
  Ostronic Francis Patrick exercised 59,881 in-the-money shares at a strike of $0.71, increasing direct ownership by 24% to 308,952 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 968d
  Sieger Markus exercised 59,881 in-the-money shares at a strike of $0.71, increasing direct ownership by 27% to 280,163 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 968d
  Tate Jeffrey exercised 29,941 in-the-money shares at a strike of $0.71, increasing direct ownership by 48% to 92,042 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 968d
  Fine N Scott exercised 299,402 in-the-money shares at a strike of $0.71, increasing direct ownership by 67% to 743,804 units (SEC Form 4)

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 1030d
  SEC Form 4: Conkling William was granted 2,449 shares

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 1030d
  SEC Form 4: Ostronic Francis Patrick was granted 10,111 shares, increasing direct ownership by 4% to 259,182 units

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 1030d
  SEC Form 4: Shanahan William S was granted 9,835 shares, increasing direct ownership by 11% to 99,483 units

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 1030d
  SEC Form 4: Sieger Markus was granted 16,269 shares, increasing direct ownership by 8% to 220,282 units

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 1030d
  SEC Form 4: Strattan Ce Rick was granted 8,089 shares, increasing direct ownership by 4% to 228,825 units

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)
• 1030d
  SEC Form 4: Toig Randall M. was granted 8,732 shares, increasing direct ownership by 11% to 88,513 units

  4 - Cyclo Therapeutics, Inc. (0000922247) (Issuer)

Other CYTH categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends